A refractory fixed drug reaction to a dye used in an oral contraceptive

Cutis

Volumn 74, Issue 4, 2004, Pages 243-244

  Ritter, Steven E ^a   Meffert, Jeffrey ^b  

^a WRIGHT PATTERSON AIR FORCE BASE   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; DYE;

ADULT; ANAMNESIS; CASE REPORT; DISEASE ACTIVITY; DRUG ERUPTION; DRUG WITHDRAWAL; FEMALE; HUMAN; ORAL CONTRACEPTION; RECURRENT DISEASE; REFRACTORY PERIOD; REVIEW;

ADULT; COLORING AGENTS; CONTRACEPTIVES, ORAL, COMBINED; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; FACE; FEMALE; FOOD COLORING AGENTS; HUMANS; TIME FACTORS;

EID: 7744240098     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Wintroub BU, Stern R. Cutaneous drug reactions: pathogenesis and clinical classification. J Am Acad Dermatol. 1985;13:167-179.
2. Seghal VN, Gangwani OP. Fixed drug eruption current concepts. Int J Dermatol 1987;6:67-74.
3. Browne SG. Fixed eruption in deeply pigmented subjects: clinical observations on 350 patients. BMJ. 1964;2:1041-1044.
4. Bork K. Fixed drug eruptions. In: Cutaneous Side Effects of Drugs. Philadelphia, Pa: WB Saunders Company; 1988:98-108.
5. Chargin L, Leiter W. Fixed eruptions due to the arsphenamines. J Invest Dermatol 1940;3:443-463.
6. Ortho Tri-Cyclen [package insert]. Raritan, NJ: Ortho-McNeil Pharmaceuticals, Inc; March 2001.
7. Rapaport MJ. Allergy to yellow dyes. Arch Dermatol. 1984;120:535-536.
8. Lockey SD Sr. Hypersensitivity to tartrazine (FD&C Yellow No. 5) and other dyes and additives present in foods and pharmaceutical products. Ann Allergy. 1977;38:206-210.
9. Litt JZ. Oral contraceptives. In: Litt JZ, ed. Drug Eruption Reference Manual. New York, NY: Parthenon Publishing Group; 2004:362-364.
10. Coskey RJ. Eruptions due to oral contraceptives. Arch Dermatol. 1977;113:333-334.